India to Morocco: Paclitaxel Export Trade Route
India has recorded 83 verified shipments of Paclitaxel exported to Morocco, representing a combined trade value of $4.6M USD. This corridor is served by 9 active Indian exporters, with an average shipment value of $55.0K USD. The leading Indian exporter is ACCURE LABS PRIVATE LIMITED, which accounts for 51% of total export value with 32 shipments worth $2.3M USD. On the buying side, P P is the largest importer in Morocco with $644.4K USD in purchases. The top 3 suppliers — ACCURE LABS PRIVATE LIMITED, VENUS REMEDIES LIMITED, SP ACCURE LABS PRIVATE LIMITED — together control 82% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Morocco Paclitaxel corridor is one of India's established pharmaceutical export routes, with 83 shipments documented worth a combined $4.6M USD. The route is dominated by ACCURE LABS PRIVATE LIMITED, which alone accounts for roughly 51% of all export value, reflecting the consolidated nature of India's paclitaxel manufacturing sector.
Across 9 active suppliers, the average shipment value stands at $55.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (30%) and air (70%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during April-June, with an average transit time of 20 days port-to-port. The route has recorded an annual growth rate of 5.5%, placing it at rank #5 among India's top paclitaxel export destinations globally.
On the import side, key buyers of Indian paclitaxel in Morocco include P P, NA, BANQUE POPULAIRE B P and 15 others. P P is the single largest importer with 10 shipments valued at $644.4K USD.
